A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
(Q24607479)
scientific article published on December 7, 2010
scientific article published on December 7, 2010
Language:
Current Data About
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma